News
![ImmunoPrecise Antibodies Announces Grant of Stock Options: https://mms.businesswire.com/media/20210203005983/en/857090/5/ImmunoPrecise_logo_HZ_PMS.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeWtBVmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--000b3982bf8e90eb30a01cca9649be03b0baae66/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/ImmunoPrecise_logo_HZ_PMS.jpg?locale=us)
ImmunoPrecise Antibodies Announces Grant of Stock Options
IMMUNOPRECISE ANTIBODIES LTD. (“IPA” or the “Company”) (NASDAQ: IPA) (TSXV: IPA), a leader in full-service, therapeutic antibody discovery, today announced that on January 13, 2022 its board of
![Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.http://www.icatcher.com/wp-content/uploads/2012/04/Symantec.jpg: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12176/Symantec.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBdEVCIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--1b3c47f309e54c35ff476143bba270ac36f5bc61/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Symantec.jpg?locale=us)
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
![Alliance Resource Partners, L.P. Announces Fourth Quarter 2021 Earnings Conference Call: https://mms.businesswire.com/media/20210412005210/en/1052735/5/LOGO_ARLP.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL2haVmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d7bc43d58083f641040bdb8aee39cb1bee5b5f5c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/LOGO_ARLP.jpg?locale=us)
Alliance Resource Partners, L.P. Announces Fourth Quarter 2021 Earnings Conference Call
Alliance Resource Partners, L.P. (NASDAQ: ARLP) will report its fourth quarter 2021 financial results before the market opens on Monday, January 31, 2022. Alliance management will discuss these
DGAP-News: GEA Group Aktiengesellschaft: A capital market information
DGAP-News: CureVac Chief Technology Officer to Pursue New Career outside Biotech Industry
EQS-News: Nordea Bank Abp: Transaction in Own Shares
![Sensorion Updates on SENS-401 Phase 2 trial in Sudden Sensorineural Hearing Loss: https://mms.businesswire.com/media/20210609005851/en/705797/5/logo-sensorion2.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK0dxVmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--df3db62501cd2dac51e6a4832a420790d1de65b6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/logo-sensorion2.jpg?locale=us)
Sensorion Updates on SENS-401 Phase 2 trial in Sudden Sensorineural Hearing Loss
Regulatory News:
Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and
![Lomiko Updates Private Placement: https://mms.businesswire.com/media/20210312005102/en/864833/5/LomikoLogo%28horizontal-colour%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMm8yVmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b227a80ff15db7af463ab5c7bed9389990f976d9/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/LomikoLogo-28horizontal-colour-29.jpg?locale=us)
Lomiko Updates Private Placement
Further to the press release dated January 7, 2022, Lomiko Metals Inc. (TSX.V: LMR) (“Lomiko Metals” or the “Company”), subject to the approval of the TSX Venture Exchange for a non-brokered
![EPR Properties Announces Tax Status of 2021 Distributions: https://mms.businesswire.com/media/20191216005756/en/351563/5/epr_hor_tag_color_pos_jpg.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK3JwRnc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ce1a1d07886968b774892358b264563207fa1632/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/epr_hor_tag_color_pos_.jpg?locale=us)
EPR Properties Announces Tax Status of 2021 Distributions
EPR Properties (NYSE: EPR) today announced the 2021 year-end tax reporting information for 2021 distributions made to shareholders. Shareholders are encouraged to consult with their personal tax
![Royal Gold Presenting at the TD Securities Global Mining Conference (Virtual): https://mms.businesswire.com/media/20191106005902/en/190143/5/Royal_Gold_Logo_-_no_shadow_-_Mar_07.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOXNsRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3d67b61076d94be393538149881101cfcf4f8cab/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Royal_Gold_Logo_-_no_shadow_-_Mar_07.jpg?locale=us)
Royal Gold Presenting at the TD Securities Global Mining Conference (Virtual)
Royal Gold, Inc. (NASDAQ: RGLD) (together with its subsidiaries, “Royal Gold” or the “Company,” “we” or “our”) announced today that management will present in the TD Securities Global Mining
![Essex Reports Characteristics of 2021 Dividends: https://mms.businesswire.com/media/20191108005660/en/625771/5/Essex_Logo_Black_%28002%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK000RUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--8ac7bfe485aea5b16eaa27ea6770ab98462dab33/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Essex_Logo_Black_-28002-29.jpg?locale=us)
Essex Reports Characteristics of 2021 Dividends
Essex Property Trust, Inc. (NYSE:ESS) announced today the income tax treatment for its 2021 distributions to shareholders. The 2021 distribution characteristics are as follows:
Common Stock –
![U.S. FDA Approves Pfizer’s CIBINQO® (abrocitinib) for Adults with Moderate-to-Severe Atopic Dermatitishttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZHc9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--be1a2af5756eaa0acf5414ead3504a7e3ad45f8a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Pfizer.jpg?locale=us)
U.S. FDA Approves Pfizer’s CIBINQO® (abrocitinib) for Adults with Moderate-to-Severe Atopic Dermatitis
Pfizer Inc. (NYSE: PFE) announced today that the United States (U.S.) Food and Drug Administration (FDA) approved CIBINQO® (abrocitinib), an oral, once-daily, Janus kinase 1 (JAK1) inhibitor, for
![ADTRAN, Inc. to Release Fourth Quarter 2021 Earnings on February 2, 2022: https://mms.businesswire.com/media/20200121005937/en/37691/5/ADTRAN_high-res.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBd3paSGc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--68f0751fd5cdf23863464caabf4ce2c1e22e53d6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/ADTRAN_high-res.jpg?locale=us)
ADTRAN, Inc. to Release Fourth Quarter 2021 Earnings on February 2, 2022
ADTRAN, Inc. (NASDAQ: ADTN) announced today that the Company will release its financial results for the fourth quarter 2021 after market close on Wednesday, February 2, 2022. The Company will
DGAP-Adhoc: Siltronic AG: No progress on the German investment review of the public takeover by GlobalWafers
DGAP-Adhoc: RHÖN-KLINIKUM AG has reached an agreement with the State of Hesse on letter of intent on public investment subsidies
![ProtoKinetix Announces Annual General Stockholder Meeting Will Be Held Virtually Only: https://mms.businesswire.com/media/20200211005387/en/772640/5/ProtoKinetix_logo_Revised.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeC9OSWc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--f3e9f99f5ff0d8d1317fd68022934ba36d2c743b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/ProtoKinetix_logo_Revised.jpg?locale=us)
ProtoKinetix Announces Annual General Stockholder Meeting Will Be Held Virtually Only
ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB: PKTX), a clinical-stage biomedical company, today announced that it will hold its Annual General Meeting
![Keysight First to Submit 5G Protocol Test Cases to 3GPP – Accelerating Adoption of Rel-16 Specifications: https://mms.businesswire.com/media/20191105005173/en/754303/5/Keysight_Signature_Pref_Color.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM1VqRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--bca68eb5e804e1802db2e2b6ef512db960c90ff6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Keysight_Signature_Pref_Color.jpg?locale=us)
Keysight First to Submit 5G Protocol Test Cases to 3GPP – Accelerating Adoption of Rel-16 Specifications
Keysight Technologies, Inc. (NYSE: KEYS), a leading technology company that delivers advanced design and validation solutions to help accelerate innovation to connect and secure the world
![Real Matters to Hold Virtual Annual General Meeting on January 31, 2022: https://mms.businesswire.com/media/20191121005199/en/554103/5/RM_high_res_logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL2lwRWc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--8924b42f63f36c742f555033e951377117803e21/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/RM_high_res_logo.jpg?locale=us)
Real Matters to Hold Virtual Annual General Meeting on January 31, 2022
Real Matters Inc. (“Real Matters”), a leading network management services provider for the mortgage lending and insurance industries, will be holding its Annual General Meeting (the “Meeting”) on
![Real Matters to Announce First Quarter Fiscal 2022 Financial Results on January 28, 2022: https://mms.businesswire.com/media/20191121005199/en/554103/5/RM_high_res_logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL2lwRWc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--8924b42f63f36c742f555033e951377117803e21/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/RM_high_res_logo.jpg?locale=us)
Real Matters to Announce First Quarter Fiscal 2022 Financial Results on January 28, 2022
Real Matters Inc. (“Real Matters”), a leading network management services provider for the mortgage lending and insurance industries, will announce its first quarter financial results via news
DGAP-News: Frankfurt/Main Higher Regional Court appoints Holger Giese, Friedrich Munsberg and Dr Ulrich Theileis to the Supervisory Board of Aareal Bank
![Consumers Prioritize Protection Over Convenience in McAfee 2022 Trends Survey](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Consumers Prioritize Protection Over Convenience in McAfee 2022 Trends Survey
McAfee’s 2022 Global Trends Study, released today, reveals U.S. consumers’ greater perceived risk of exposure to online threats for individuals and family members, and a corresponding desire to
![HAEMATO distributes PCR point-of-care devices for effective containment of corona pandemichttp://www.haemato-ag.de/: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/13910/haematoLogo.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBWlE9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--53b91026ff232fa7aa2f7da83a280c15c28ca459/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/haematoLogo.png?locale=us)
HAEMATO distributes PCR point-of-care devices for effective containment of corona pandemic
![CI Global Asset Management Announces January 2022 Distributions for CI ETFs: https://mms.businesswire.com/media/20201105006022/en/836403/5/CI-F_-_RGB_E.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBem1LVlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3d8fb424903fcea7ece1d64c4b0c3bb9003ef63e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/CI-F_-_RGB_E.jpg?locale=us)
CI Global Asset Management Announces January 2022 Distributions for CI ETFs
CI Global Asset Management (“CI GAM”) announces the following regular cash distributions for the month ending January 31, 2022 in respect of CI ETFs. In all cases, the distribution will be paid on
![Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.http://www.icatcher.com/wp-content/uploads/2012/04/Symantec.jpg: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12176/Symantec.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBdEVCIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--1b3c47f309e54c35ff476143bba270ac36f5bc61/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Symantec.jpg?locale=us)